Next Article in Journal
Reply to Auclin et al. Comment on “Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176”
Next Article in Special Issue
Methylosystem for Cancer Sieging Strategy
Previous Article in Journal
From Distress Screening to Uptake: An Italian Multicenter Study of Cancer Patients
Previous Article in Special Issue
Identification of Pre-Diagnostic Metabolic Patterns for Glioma Using Subset Analysis of Matched Repeated Time Points
 
 
Article

Article Versions Notes

Cancers 2021, 13(15), 3762; https://doi.org/10.3390/cancers13153762
Action Date Notes Link
article xml file uploaded 27 July 2021 09:35 CEST Original file -
article xml uploaded. 27 July 2021 09:35 CEST Update https://www.mdpi.com/2072-6694/13/15/3762/xml
article pdf uploaded. 27 July 2021 09:35 CEST Version of Record https://www.mdpi.com/2072-6694/13/15/3762/pdf
article supplementary file uploaded. 27 July 2021 09:35 CEST - https://www.mdpi.com/2072-6694/13/15/3762#supplementary
article html file updated 27 July 2021 09:36 CEST Original file -
article html file updated 27 July 2022 06:40 CEST Update https://www.mdpi.com/2072-6694/13/15/3762/html
Back to TopTop